Results 91 to 100 of about 8,929 (178)

Janus kinase inhibitors in localized scleroderma: a systematic literature review. [PDF]

Turk J Med Sci
Şener S, Şener YZ, Batu ED, Sari A, Akdoğan A.   +4 more
europepmc   +1 more source

The Therapeutic Effects of Semaglutide in Congenital Linear Scleroderma. [PDF]

Cureus
Chen H, Elhawi M, Tarbox M.
europepmc   +1 more source

Temporal dynamics of ADSC therapy in skin fibrosis: unraveling the roles of ROS/NF-κB/TSG-6 signaling axis. [PDF]

Stem Cell Res Ther
Wang L, Li T, Ma X, Li Z, Xiang J, Tseng S, Yu N, Huang J, Long X.   +8 more
europepmc   +1 more source

Devastating neurologic consequences of localized scleroderma en coup de sabre of the scalp-2 case studies. [PDF]

J Scleroderma Relat Disord
Ma C, Legault K, Provias J, Zhang E, Gallienne C, Larche M.   +5 more
europepmc   +1 more source

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. [PDF]

Blood
Newton NM, Agrawal K, Odell AV, Tracy T, Hackett C, Eldrup A, Whitfield M, Martyanov V, Girardi M, Sefik E, Flavell RA, Odell ID.   +11 more
europepmc   +1 more source

Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma Mimic. [PDF]

Cureus
Shammas R, Gudino-Rosales S, Kneiber D, Sarantopoulos GP, Aung T.   +4 more
europepmc   +1 more source

Juvenile Localized Scleroderma [PDF]

, 2020
openaire   +1 more source

Editorial: Understanding scleroderma: symptoms, causes, treatment options, and advanced diagnostic techniques. [PDF]

Front Immunol
Ostojic P.
europepmc   +1 more source

A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseases. [PDF]

Front Med (Lausanne)
Volc S, Martus P, Schefzyk M, Günther C, Moinzadeh P, Susok L, Ferrer RA, Zago M, Pfeiffer C.   +8 more
europepmc   +1 more source

Ustekinumab-associated morphoea: systematic review of the literature and a real-world case. [PDF]

Drugs Context
Sousa M, Alvarenga JM, Lé AM, Torres T.
europepmc   +1 more source